Finance

Lists
Why is 001060 up 3,69%?
Dive Deeper
001060:KRX
JW Pharmaceutical Corp
25 300,00 KRW
+3,69%
(+900,00) 1D
16 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001060...
Open
24 500 KRW
High
25 550 KRW
Low
24 500 KRW
Mkt. cap
607,55 მლრ.
Avg. vol.
53,58 ათ.
Volume
33,07 ათ.
Dividend
2,57%
Quarterly dividend
163 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
6,03
52-wk high
39 250 KRW
52-wk low
21 550 KRW
EPS
4 193 KRW
Shares outstanding
23,29 მლნ.
No. of employees
1 ათ.
Open
24 500 KRW
High
25 550 KRW
Low
24 500 KRW
Mkt. cap
607,55 მლრ.
Avg. vol.
53,58 ათ.
Volume
33,07 ათ.
Dividend
2,57%
Quarterly dividend
163 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
6,03
52-wk high
39 250 KRW
52-wk low
21 550 KRW
EPS
4 193 KRW
Shares outstanding
23,29 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About JW Pharmaceutical Corp
CEOლი, კიუნგ ჰა
Employees1,05 ათ.
Founded1945
Headquarters-
SectorPharmaceutical industry
Websitejw-pharma.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
200,02 მლრ.
198,94 მლრ.
199,88 მლრ.
222,02 მლრ.
Cost of goods sold
105,39 მლრ.
109,09 მლრ.
101,43 მლრ.
116,73 მლრ.
Cost of revenue
105,39 მლრ.
109,09 მლრ.
101,43 მლრ.
116,73 მლრ.
Research and development expenses
7,33 მლრდ.
15,27 მლრდ.
9,38 მლრდ.
11,86 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 მლრდ.
60,42 მლრდ.
55,91 მლრდ.
59,90 მლრდ.
Operating expense
62,60 მლრდ.
80,98 მლრდ.
64,88 მლრდ.
71,95 მლრდ.
Total operating expenses
167,99 მლრ.
190,07 მლრ.
166,31 მლრ.
188,68 მლრ.
Operating income
32,03 მლრდ.
8,87 მლრდ.
33,58 მლრდ.
33,34 მლრდ.
Other non operating income
-4,64 მლრდ.
8,03 მლრდ.
1,21 მლრდ.
835,27 მლნ.
EBT including unusual items
27,85 მლრდ.
17,49 მლრდ.
35,20 მლრდ.
34,76 მლრდ.
EBT excluding unusual items
27,85 მლრდ.
15,96 მლრდ.
35,20 მლრდ.
34,76 მლრდ.
Income tax expense
-2,74 მლრდ.
2,18 მლრდ.
7,72 მლრდ.
6,86 მლრდ.
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 მლრდ.
15,32 მლრდ.
27,48 მლრდ.
27,89 მლრდ.
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 ათ.
-
-
-
Interest and investment income
-
3,34 მლრდ.
-
-
Interest expense
-
-4,42 მლრდ.
-
-
Net interest expenses
-
-1,09 მლრდ.
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 მლრდ.
13,65 მლრდ.
38,56 მლრდ.
38,37 მლრდ.
Gain or loss from assets sale
5,12 მლნ.
3,00 ათ.
-10,00 მლნ.
3,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები